1.A New Vomifoliol Derivative and Flavonoids from the Aerial Parts ofOrthosiphon aristatus
Hye Jin KIM ; Kye Jung SHIN ; Khin Myo HTWE ; Kee Dong YOON
Natural Product Sciences 2024;30(2):72-79
Orthosiphon aristatus (Lamiaceae) is a perennial herbaceous plant native to tropical Southeast Asia countries. The chemical investigation on this plant led to the isolation and structure elucidation of a new vomifoliol derivative (1) along with eighteen known phenolic compounds [cystosiphonin (2), 5,7,8-trimethoxyflavanone (3), scutellarein-7,4′-methylether (4), eupatorin (5), 5,6,7,8,4′-pentamethoxyflavone (6), 5,6,7,4′-tetramethylscutellarein (7), 5,6,7,8,3′,4′-hexamethoxyflavone (8), 6-hydroxy-5,7,4′-trimethoxyflavone (9), 6,7,8,3′,4′-pentamethoxyflavone (10), 5,6,3′-trihydroxy-7,4′-dimethoxyflavone (11), 5,6-dihydroxy-7,3′,4′-trimethoxy flavone (12), 4′-hydroxy-5,6,7,3′-tetramethoxyflavone (13), 2′-hydroxy-3,4,4′,5′,6′-pentamethoxy-chalcone (14), isoquercetin (15), quercetin 3-O-α-L-arabinopyranosyl (1→6)-β-Dglucopyranoside (16), caffeic acid (17), rosmarinic acid (18), and (6S,9R)-roseoside (19)]. The structures of isolates were confirmed via spectroscopic data such as one- and two-dimensional nuclear magnetic resonance,circular dichroism, mass, ultraviolet and optical rotation.
2.Incidence and Predictors of Cataract among People with Type 2 Diabetes Mellitus: Using Secondary Data Analysis from the Ansan Cohort of the Korean Genome and Epidemiology Study
Ihn Sook JEONG ; Eun Joo LEE ; Myo Sung KIM ; Jung Ok YU ; Hae Sun YUN ; Jeong Hee JEONG ; Youn Sun 6 HWANG
Journal of Korean Academy of Nursing 2022;52(1):24-35
Purpose:
This study investigated the incidence and risk factors of cataract in people with diabetes mellitus (DM) using data from Ansan cohort of the Korean Genome and Epidemiology Study (KoGES).
Methods:
Data from a total of 329 patients with type 2 DM without cataract who participated in Ansan cohort of the KoGES from baseline survey (2001–2002) to fifth follow-up visit (2011–2012) were examined.The characteristics of the subjects were analyzed with frequency and percentage, and mean and standard deviation. Cataract incidence was measured as incidence proportion (%). For risk factors of cataract, hazard ratio (HR) and 95% confidence interval (CI) were obtained using the Cox proportional hazard model.
Results:
The cataract incidence over a 10-year follow-up period was 19.1% (15.1 in males and 25.8 in females), and mean age at the incidence of cataract was 63.48 years (61.58 years in males and 65.31 years in females). Age (HR=1.09, 95% CI=1.05–1.13) and HbA1c (HR=1.21, 95% CI=1.07–1.37) or the duration of DM (HR=1.05, 95% CI=1.00–1.09) were found to be independently associated with cataract development.
Conclusion
Cataract development in people with DM is common, and its likelihood increases with age, HbA1c, and the duration of DM. Considering negative effect of cataract on their quality of life and economic burden, nurses should identify people with DM at a higher risk of cataract development, and plan individual eye examination programs to detect cataract development as early as possible.
3.A case of cow’s milk-induced eosinophilic enterocolitis masquerading as necrotizing enterocolitis in a preterm infant with extremely low birth weight
Sun-Young LEE ; Myo-Jing KIM ; Jin-A JUNG ; Seo-Hee RHA ; Chae-Ku JO
Allergy, Asthma & Respiratory Disease 2022;10(4):215-218
Food allergy is a rare form of feeding intolerance in preterm infants, with symptoms similar to necrotizing enterocolitis. We report a case of clinically diagnosed cow’s milk-induced eosinophilic enterocolitis in an infant with extremely low birth weight. The patient was born at 24 weeks and 1 day gestation, weighing 610 g, had repeated episodes of gastrointestinal symptoms after feeding, and was placed on nil per os. On day 67, the eosinophil count increased suddenly (7,852.8/mL), and the formula was changed to amino acid-based (Neocate). Gradually, the eosinophil count returned to normal. Ileostomy was performed and full enteral feeding was achieved with Neocate. Intraoperatively, the intestine was nonnecrotic and viable; the biopsy report showed massive mucosal eosinophilic infiltration. The patient was diagnosed with cow’s milk-induced eosinophilic enterocolitis.
4.A Study on the Manual Lymph Drainage and Programs for Specialist: a Literature Review
Jung-myo SHIM ; Gi-Cheol KIM ; Seong-jung KIM
Journal of Korean Physical Therapy 2022;34(4):129-134
It is necessary to produce properly educated Manual Lymph Drainage (MLD) specialists conducted by certified instructors. This study was conducted to introduce a comprehensive understanding, application, historical background, and effect of the MLD and to present a basis for using the frequency MLD as a basic resource for training professional. MLD, a field of manual therapy, is used to treat a variety of diseases such as joint disease, circulatory system disease, lymphedema, and pain et al. However, since there is no proper education for MLD in Korea, there is a need to provide education that meets internationally accepted standards. The Physical Therapists Association and related academic societies will need to prepare a system to train specialists on MLD and to recognize medical insurance through it.
5.Patterns of Spontaneous Adverse Events Reporting on Human Papillomavirus Vaccines according to the Applicability of Brighton Collaboration Criteria in Korea from 2008 to 2017
Myo-Song KIM ; Seung-Hun YOU ; Hye Min PARK ; Min-Taek LEE ; Ye-Jin KANG ; Hyunji KOO ; Sun-Young JUNG
Korean Journal of Clinical Pharmacy 2020;30(1):19-30
Objective:
To describe patterns of spontaneous reporting on adverse events following immunization (AEFIs) using the human papilloma virus (HPV) vaccine according to the Brighton Collaboration (BC) criteria.
Methods:
We used the Korea Adverse Event Reporting System (KAERS) database including vaccinations between 2008 and 2017. To apply BC criteria, we classified 58 BC AEFIs into World Health Organization Adverse Reaction Terminology (WHO-ART) codes. We applied MedDRA standard medical queries that were pre-defined as five BC AEFIs. Terminology mapping between MedDRA and WHO-ART terms was performed by three researchers. Descriptive statistics of individual case safety reports were analyzed according to BC applicability.Disproportionality analyses were performed on each BC AEFI and each preferred AEFI term according to the case-noncase approach; reporting odds ratio (ROR) and 95% confidence intervals (CI) were calculated.
Results:
Among the 30,266 reports of vaccinations between 2008 and 2017, 2,845 reports included the HPV vaccine. Of these reports, 1,511 (53.1%) included at least one BC AEFI. Reports from physicians or manufacturers included more BC AEFIs than from other reporters. Injection site reactions and fever were frequently reported in BC AEFIs; spontaneous abortion and ectopic pregnancy (ROR, 14.29 [95% CI, 4.30-47.49]) and vasculitic peripheral neuropathy (ROR, 8.57 [95% CI, 2.61-28.10]) showed the highest ROR. Among non-BC AEFIs, dizziness or myalgia were frequently reported; exposure during pregnancy (ROR, 23.95 [95% CI, 16.27-35.25]) and inappropriate schedule of administration (ROR, 22.89 [95% CI, 16.74-31.31]) showed the highest ROR.
Conclusion
BC criteria would be applicable for labeled AEFIs, whereas analyzing non-BC AEFIs would be useful for detecting unlabeled AEFIs.
6.Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
Min-Taek LEE ; Kwang-Yeol PARK ; Myo-Song KIM ; Seung-Hun YOU ; Ye-Jin KANG ; Sun-Young JUNG
Yonsei Medical Journal 2020;61(9):741-749
Purpose:
Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used in patients with atrial fibrillation (AF) because of their effectiveness in preventing stroke and their better safety, compared with warfarin. However, there are concerns for an increased risk of bleeding associated with concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) or selective serotonin reuptake inhibitors (SSRIs) with NOACs. In this study, we aimed to evaluate the risk of bleeding events in individuals taking concomitant NSAIDs or SSRIs with NOACs after being diagnosed with AF. Materials and Methods: A nested case-control analysis to assess the safety of NSAIDs and SSRIs among NOAC users with AF was performed using data from Korean National Health Insurance Service from January 2012 to December 2017.Among patients who were newly prescribed NOACs, 1233 cases hospitalized for bleeding events were selected, and 24660 controls were determined.
Results:
The risk of bleeding events was higher in patients receiving concomitant NSAIDs [adjusted odds ratio (aOR) 1.41; 95% confidence interval (CI) 1.24–1.61] or SSRIs (aOR 1.92; 95% CI 1.52–2.42) with NOACs, compared to no use of either drug, respectively.The risk of upper gastrointestinal bleeding was higher in patients receiving concomitant NSAIDs or SSRIs without proton pump inhibitors (PPIs) (NSAIDs: aOR 2.47; 95% CI 1.26–4.83, SSRI: aOR 10.8; 95% CI 2.41–2.48) compared to no use.
Conclusion
When NSAIDs or SSRIs are required for NOAC users with AF, physicians need to monitor bleeding events and consider the use of PPIs, especially for combined use of both drugs or when initiating NOACs treatment.
7.Conducting and Reporting a Clinical Research Using Korean Healthcare Claims Database
Seonji KIM ; Myo-Song KIM ; Seung-Hun YOU ; Sun-Young JUNG
Korean Journal of Family Medicine 2020;41(3):146-152
An increasing number of studies are using healthcare claims databases to assess healthcare intervention utilization patterns or outcomes in real-world clinical settings. However, methodological issues affecting study design or data analysis can make conducting and reporting these types of studies difficult. This review presents an overview of the types of information contained in claims data, describes some advantages and limitations of using claims data for research purposes, and outlines steps for utilizing the Korea Health Insurance Review and Assessment and National Health Insurance Service databases. The study also reviews epidemiological approaches utilizing healthcare claims databases (including cross-sectional, case-control, case-crossover, and cohort designs) with respect to protocol development, analysis, and reporting of results, and introduces relevant guidelines and checklists, including the Guidelines for Good Pharmacoepidemiology Practices, the Strengthening the Reporting of Observational Studies in Epidemiology checklist, and the Risk of Bias in Nonrandomized Studies of Interventions tool.
8.Patterns of Spontaneous Adverse Events Reporting on Human Papillomavirus Vaccines according to the Applicability of Brighton Collaboration Criteria in Korea from 2008 to 2017
Myo-Song KIM ; Seung-Hun YOU ; Hye Min PARK ; Min-Taek LEE ; Ye-Jin KANG ; Hyunji KOO ; Sun-Young JUNG
Korean Journal of Clinical Pharmacy 2020;30(1):19-30
Objective:
To describe patterns of spontaneous reporting on adverse events following immunization (AEFIs) using the human papilloma virus (HPV) vaccine according to the Brighton Collaboration (BC) criteria.
Methods:
We used the Korea Adverse Event Reporting System (KAERS) database including vaccinations between 2008 and 2017. To apply BC criteria, we classified 58 BC AEFIs into World Health Organization Adverse Reaction Terminology (WHO-ART) codes. We applied MedDRA standard medical queries that were pre-defined as five BC AEFIs. Terminology mapping between MedDRA and WHO-ART terms was performed by three researchers. Descriptive statistics of individual case safety reports were analyzed according to BC applicability.Disproportionality analyses were performed on each BC AEFI and each preferred AEFI term according to the case-noncase approach; reporting odds ratio (ROR) and 95% confidence intervals (CI) were calculated.
Results:
Among the 30,266 reports of vaccinations between 2008 and 2017, 2,845 reports included the HPV vaccine. Of these reports, 1,511 (53.1%) included at least one BC AEFI. Reports from physicians or manufacturers included more BC AEFIs than from other reporters. Injection site reactions and fever were frequently reported in BC AEFIs; spontaneous abortion and ectopic pregnancy (ROR, 14.29 [95% CI, 4.30-47.49]) and vasculitic peripheral neuropathy (ROR, 8.57 [95% CI, 2.61-28.10]) showed the highest ROR. Among non-BC AEFIs, dizziness or myalgia were frequently reported; exposure during pregnancy (ROR, 23.95 [95% CI, 16.27-35.25]) and inappropriate schedule of administration (ROR, 22.89 [95% CI, 16.74-31.31]) showed the highest ROR.
Conclusion
BC criteria would be applicable for labeled AEFIs, whereas analyzing non-BC AEFIs would be useful for detecting unlabeled AEFIs.
9.Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer.
Jee Min CHUNG ; Yongsik JUNG ; Young Pil KIM ; Jinsue SONG ; Soyeon KIM ; Ji Young KIM ; Mira KWON ; Jung Hyun YOON ; Myo Deok KIM ; Jun Kyoung LEE ; Da Yoon CHUNG ; Seo Yun LEE ; Jooseong KANG ; Ho Chul KANG
Journal of Breast Cancer 2018;21(1):87-90
Triple-negative breast cancer (TNBC) has a higher risk of death within 5 years of being diagnosed than the other forms of breast cancer. It is the second leading cause of death due to cancer among women. Currently, however, no diagnostic blood-based biomarker exists to identify the early stages of TNBC. To address this point, we utilized a human protein microarray system to identify serum autoantibodies that showed different expression patterns between TNBC and normal serum samples, and identified five autoantibodies showing TNBC-specific expression. Among them, we selected the thioredoxin-like 2 (TXNL2) autoantibody and evaluated its diagnostic relevance by dot blot analysis with the recombinant TXNL2 protein. We demonstrated that the TXNL2 autoantibody showed 2- to 6-fold higher expression in TNBC samples than in normal samples suggesting that serum TXNL2 autoantibodies are potential biomarkers for TNBC.
Autoantibodies
;
Biomarkers
;
Breast Neoplasms
;
Cause of Death
;
Female
;
Humans
;
Protein Array Analysis
;
Triple Negative Breast Neoplasms*
10.Factors Affecting International Patient's Satisfaction with Korea Medical Services, Revisit and Recommendation Intention.
Myo Gyeong KIM ; Yun Kyoung CHOI ; Jung Won AHN ; Keum Soon KIM
Health Policy and Management 2017;27(1):63-74
BACKGROUND: This study aims to analyze quality of and satisfaction with Korea medical services and identify factors affecting medical service satisfaction, revisit, and recommendation intention among international patients. METHODS: Secondary analysis of survey data conducted by Korea Health Industry Development Institute from June 10th to July 17th in 2013 was done using multiple regression and logistic regression analysis. The 191 international patients from 9 medical institutions in Seoul were enrolled. RESULTS: The results showed that international patients were satisfied with 85.6 points out of 100.0 points. International patients appraised higher in staff service rather than other services. Factors influencing medical service satisfaction were gender, religion, medical specialty, length of stay, and quality of medical services. Quality of medical service explained 29.8% of medical service satisfaction and especially, ‘doctor's care’ and ‘communication and patient respect‘ were significantly related to medical service satisfaction. Medical specialty had a significant influence on revisit intention. There were no statistically significant influencing factors of recommendation intention. Additionally, more satisfied patients were associated with higher revisit and recommendation intention. CONCLUSION: This study implies that quality of medical services is a critical factor for patient satisfaction and that satisfaction with medical services is an important factor for increasing revisit and recommendation intention among international patients. In addition, health care providers should consider cultural differences to enhance satisfaction with medical services for international patients. Therefore, multidimensional strategy is required to strengthen the cultural competency of healthcare providers.
Cultural Competency
;
Health Personnel
;
Health Services
;
Humans
;
Intention*
;
Korea*
;
Length of Stay
;
Logistic Models
;
Patient Satisfaction
;
Seoul

Result Analysis
Print
Save
E-mail